Browsing Category

Supplier News

156 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

WuXi STA Launches New Small-Molecule API Facility; Expands Peptides, Oligonucleotides Capacity; Updates Drug-Product Expansions 
By

By
WuXi STA is proceeding with a major multi-site, global expansion plan  to enhance its manufacturing capabilities and capacities. Yu Lu, the Chief Business Officer of WuXi STA and Head of…

CordenPharma Announces Mfg Expansions in Peptides, Solid Dosage Products & LNP 
By

By
CordenPharma International is investing to provide expanded offerings across multiple technology platforms and facilities. Dr. Stephen Houldsworth, Senior Vice President, Global Head of Platform Management & Marketing, CordenPharma International, outlined…

AGC Pharma Chemicals Investing $100-M-Plus To Expand Small-Molecule API, High-Potency API Mfg  
By

By
AGC Pharma Chemicals is investing $100-million-plus to expand small-molecule active pharmaceutical ingredient (API) manufacturing, including high-potency API manufacturing. Akihiro Kadokura, CEO, AGC Pharma Chemicals Europe S.L.U., provided an update at…

Evotec Subsidiary Just-Evotec Biologics Adding New Facility for Continuous Biomanufacturing  
By

By
Just-Evotec Biologics, a subsidiary of Evotec, is investing in a new facility for continuous biomanufacturing. Nick Hutchinson, Head of Market Development, Just-Evotec Biologics, Evotec, provided an update at the DCAT…

ST Pharm Investing $110 M To Expand Oligonucleotide Mfg Capacity  
By

By
ST Pharm is expanding its oligonucleotide manufacturing capacity with the addition of a new plant. Kris S. Choi, Senior Vice President, Marketing & Business Development, ST Pharm, provided an update…

Kindeva Drug Delivery Investing $150 M-Plus for New Fill–Finish Facility; Acquires Nasal-Drug Delivery Company Summit Biosciences 
By

By
Kindeva Drug Delivery is making several key strategic investments in its CDMO and drug-delivery business. Milton Boyer, CEO, Kindeva Drug Delivery, outlined the company’s recent moves at the DCAT Member…

Cambrex Nears Completion of Multi-Year, $100-M Small-Molecule API Expansion  
By

By
Cambrex is nearing completion of a multi-year, $100-million expansion in small-molecule development and manufacturing. Matt Bio, Chief Scientific Officer, Cambrex, outlined the company’s recent expansion activity at the DCAT Member…

Seqens Enters Cell- & Gene-Therapy Market With Acquisition of CELLforCURE 
By

By
Seqens, a CDMO of small-molecule active pharmaceutical ingredients (APIs), intermediates, and specialty ingredients, is entering the cell- and gene-therapy market via a key acquisition. Pierre Luzeau, CEO, Seqens, provided the…

Porton Expanding Small-Molecule API Manufacturing  
By

By
Porton Pharma Solutions is investing in its small-molecule API development and manufacturing capabilities. The company’s expansion news was outlined by Oliver Ju, Chairman & CEO, Porton Pharma Solutions, at the…

BSP Pharmaceuticals Announces Multi-Year, $576-M Expansion for Cytotoxic & Non-Cytotoxic Products 
By

By
BSP Pharmaceuticals, a CDMO of drug substances and drug products, has announced a multi-year, $576-million expansion for cytotoxic and non-cytotoxic products. Anna Maria Braca, General Counsel & Vice President, Strategic…